CB Insights · Dec 2025
A secondary summary of a Medigram CEO article stressing practical execution, standards, and outcomes over AI hype.
We are making a HIPAA-compliant, Groupme app for doctors to…
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Medigram is a healthcare AI governance infrastructure company that evolved from an earlier HIPAA-compliant clinical messaging product into an on-premises, standards-driven platform for governed AI decision-making in hospitals and other high-stakes environments.
Primary product
Darwin, a governed decision platform for audit-ready healthcare AI governance
Founded
2011
Headquarters
Los Gatos, California, United States
Team size
1-10
Industry
Hospitals and Health Care
Sub-industry
Healthcare AI governance infrastructure
Offices
0 jobs at Medigram
Check back later for new openings
Business model
Stage
seed
Total raised
$120K
Latest round
Conventional Debt · Jan 2014
Jan 2014
Mar 2012 · Y Combinator
Leadership
Chief Executive Officer
Chief Medical Officer
CTO & CSO
Head of Revenue
Investors
Publicly described as selective, partner-oriented, standards-first, clinically accountable, and high-trust; the company emphasizes governance, architecture, and safety engineering over generic SaaS growth tropes.
Pricing
Enterprise/custom pricing for commissioned deployments; public site suggests initial deployment packages in the mid-six-figure range plus platform fees.
Differentiators
Technology
Customers
Competitors
Estimated revenue
≈$2M ARR (estimate)
Estimated monthly visits
28.5K
Traffic estimate as of Jun 2026
CB Insights · Dec 2025
A secondary summary of a Medigram CEO article stressing practical execution, standards, and outcomes over AI hype.
Medium · Nov 2025
Announces the AIMed25 AI Champion Award and describes Medigram’s high-reliability AI module, runtime telemetry, and standards-aligned governance infrastructure.
Medium · May 2025
Explains why healthcare AI needs runtime governance, human-in-the-loop controls, and high-consequence infrastructure instead of SaaS playbooks.
Medium · May 2025
Sherri Douville argues Medigram’s approach is governance, architecture, and safety engineering for clinical AI rather than generic SaaS.
Business Wire · Nov 2022
Announces the Taylor & Francis/Routledge book series and positions Medigram CEO Sherri Douville as series editor and leader in trustworthy technology and innovation.